Literature DB >> 8531137

Cloning and pharmacological characterization of the rabbit bradykinin B2 receptor.

D R Bachvarov1, E Saint-Jacques, J F Larrivée, L Levesque, F Rioux, G Drapeau, F Marceau.   

Abstract

Degenerate primers, corresponding to consensus sequences of third and sixth transmembrane domains of G protein-coupled receptor superfamily, were used for the polymerase chain reaction amplification and consecutive characterization of G protein-coupled receptors present in cultured rabbit aortic smooth muscle cells. One of the isolated resulting fragments was highly homologous to the corresponding region of the bradykinin (BK) B2 receptor cloned in other species. The polymerase chain reaction fragment was used to screen a rabbit genomic library, which allowed the identification of an intronless 1101-nucleotide open reading frame which codes for a 367-amino acid receptor protein. The rabbit B2 receptor sequence is more than 80% identical to the ones determined in three other species and retain putative glycosylation, palmitoylation and phosphorylation sites. In the rabbit genomic sequence, an acceptor splice sequence was found 8 base pairs upstream of the start codon. Northern blot analysis showed a high expression of a major transcript (4.2 kilobases) in the rabbit kidney and duodenum, and a less abundant expression in other tissues. Southern blot experiments suggest that a single copy of this gene exists in the rabbit genome. The cloned rabbit B2 receptor expressed in COS-1 cells binds [3H]BK in a saturable manner (KD 2.1 nM) and this ligand competes with a series of kinin agonists and antagonist with a rank order consistent with the B2 receptor identity. The insurmountable character of the antagonism exerted by Hoe 140 against BK on the rabbit B2 receptor, previously shown in pharmacological experiments, was confirmed in binding experiments with the cloned receptor expressed in a controlled manner. By contrast, Hoe 140 competed with [3H]BK in a surmountable manner for the human B2 receptor expressed in COS-1 cells. The cloning of the rabbit B2 receptor will be useful notably for the study of the structural basis of antagonist binding and for studies on receptor regulation in a relatively large animal.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8531137

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  Actions of bradykinin on electrical and synaptic behavior of neurones in the myenteric plexus of guinea-pig small intestine.

Authors:  Hong-Zhen Hu; Sumei Liu; Na Gao; Yun Xia; Randa Mostafa; Jun Ren; Dimiter H Zafirov; Jackie D Wood
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

2.  Pharmacological and functional characterization of the guinea-pig B2 bradykinin receptor stably expressed in CHO-K1 cell line.

Authors:  C Robert; D Pruneau; J-L Paquet
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

Review 3.  Kinin receptors.

Authors:  F Marceau; D R Bachvarov
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

4.  Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses.

Authors:  J L Paquet; J M Luccarini; C Fouchet; E Defrêne; B Loillier; C Robert; P Bélichard; B Cremers; D Pruneau
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

5.  Non-competitive pharmacological antagonism at the rabbit B(1) receptor.

Authors:  J F Larrivée; L Gera; S Houle; J Bouthillier; D R Bachvarov; J M Stewart; F Marceau
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

6.  Bradykinin increases Na(+)-K(+) pump activity in cultured guinea-pig tracheal smooth muscle cells.

Authors:  A M Dodson; K J Rhoden
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

7.  Trypanosoma cruzi invades host cells through the activation of endothelin and bradykinin receptors: a converging pathway leading to chagasic vasculopathy.

Authors:  Daniele Andrade; Rafaela Serra; Erik Svensjö; Ana Paula C Lima; Erivan S Ramos; Fabio S Fortes; Ana Carolina F Morandini; Verônica Morandi; Maria de N Soeiro; Herbert B Tanowitz; Julio Scharfstein
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

8.  Antagonist, partial agonist and antiproliferative actions of B-9870 (CU201) as a function of the expression and density of the bradykinin B1 and B2 receptors.

Authors:  G Morissette; S Houle; L Gera; J M Stewart; F Marceau
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

9.  Protein expression, biochemical pharmacology of signal transduction, and relation to intraocular pressure modulation by bradykinin B₂ receptors in ciliary muscle.

Authors:  Najam A Sharif; Shouxi Xu; Linya Li; Parvaneh Katoli; Curtis R Kelly; Yu Wang; Shutong Cao; Rajkumar Patil; Shahid Husain; Laura Klekar; Daniel Scott
Journal:  Mol Vis       Date:  2013-06-15       Impact factor: 2.367

10.  Pharmacological effects of recombinant human tissue kallikrein on bradykinin B2 receptors.

Authors:  Xavier Charest-Morin; Arvind Raghavan; Matthew L Charles; Tadeusz Kolodka; Johanne Bouthillier; Mélissa Jean; Mark S Robbins; François Marceau
Journal:  Pharmacol Res Perspect       Date:  2015-02-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.